Daniel Ma
@DanielMaMD
Followers
1K
Following
2K
Statuses
485
Enterprise Head & Neck Disease Group Chair @MayoCancerCare. Husband and dad. H&N Rad Onc. Oropharynx researcher. Opinions are my own. Soli Deo Gloria.
Mayo Clinic, Rochester
Joined October 2019
@aadel_chaudhuri @n_laack @CherylWillmanMD @MayoRadOnc @MayoCancerCare @MayoClinic So happy to have you as part of the team!
1
0
2
RT @DavidSherMD: Tremendous work by my good friend and @UTSWENT colleague Dr. Andrew Day to discuss the impact of RT on carotid artery ste…
0
4
0
Finalizing the @ABR_Radiology HN oral exam with a wonderful group of dedicated individuals. Honored to be part of this group.
0
1
39
@Soum_Roy_RadOnc @EbnerMD @DavidRoutmanMD @TheColonelGray @JWilsonOkun @tmalouff @n_laack @MayoRadOnc We are so excited to have you join us Dan!
0
0
3
RT @franklinliu1019: Welcome to join our educational session on Linear Energy Transfer (LET) and Relative Biological Effectiveness (RBE) in…
0
2
0
@DrMLChua @DrGopalIyer @P_Shams_ @sueyom @RTOGFoundation @NRGonc @ASTRO_org Radiation is inherently stochastic so clonagen burden could become important with de-escalation. I don’t think it’s an accident that the most successful post-op de-escalation in DART has been in the intermediate risk cohort, where pts have only microscopic residual. My 2 cents.
0
0
2
RT @OmranSaifi: Truly honored to receive @RO_Institute pub excellence award for work on RT+CAR-T! Grateful for mentors @HoppeBrad @MKD_BMT…
0
4
0
RT @franklinliu1019: Our paper entitled: “Online Adaptive Proton Therapy Facilitated by Artificial Intelligence-based Auto Segmentation in…
0
7
0
RT @NiuSanford: Remarkable case report. RT for leonine facies in CTCL. 20 Gy/4 fx protons then 12 Gy/8 fx electrons – completely life cha…
0
56
0
RT @aadel_chaudhuri: Indeed! @MayoRadOnc is also THE place to be if you’re interested in Holman pathway and physician-scientist track. Pr…
0
3
0
@CJTsaiMDPhD @imrtlee @MSK_RadOnc @lucmorrisnyc @max_diehn @xrtGenomics @seanmmcbride @yaoyu_md @ScottBratman @Esanzgarcia @DrJohndeAlmeida @YaoCMKL @DavidSherMD @KaramLab Excellent and thought provoking. Based on the work by @DavidRoutmanMD , the view of @MayoRadOnc has been that ctHPVDNA needs to be used to refine pathologic risk factors, rather than in lieu of pathologic risk factors for clinical trials, for reasons outlined here.
1
3
13
RT @AriRosenbergMD: Excited that our OPTIMA II trial is out in @JAMAOnc! Neoadjuvant nivo/chemo -> response-adaptive treatment for HPV+ oro…
0
15
0
Congratulations to @imrtlee and team for this exciting work! Biologically selected treatment individualization should be the future direction for all HNC.
🚨📢Happening now - HN oral abstracts #ASCO24‼️ PRACTICE CHANGING trial of hypoxia directed major radiation de-escalation as definitive treatment for HPV+OPC by @imrtlee @MSK_RadOnc @MSKCancerCenter, showing that 30Gy+Chemo is sufficient for cure, with > 500 pts treated so far. 🗣️Why should everyone be treated to 70Gy with large elective dose/volume ⁉️ Radiation does not have to be toxic in many selected patients based on hypoxia status. @xrtGenomics @imrtlee @seanmmcbride @YaoCMKL
@yaoyu_md @Esanzgarcia @DrMLChua @KaramLab
@Dealmakertech @DanielMaMD @ScottBratman @JJCaudell @safaviaa @HenryParkMD @ajuloorimd @henson_md @RobertFerrisMD @ezrahahn @Dr_AliHosni @lucmorrisnyc @DavidSherMD @LChen_MD
0
1
16
Tremendous work on IMPT vs IMRT for OPC at #ASCO2024 Much credit to @SJFrankMD and team for pulling off a very challenging randomization!
‼️🚨Happening now - HN oral abstracts #ASCO24 Much anticipated Ph3 IMPT vs IMRT for OPC presented by @SJFrankMD @MDAndersonNews A tremendous effort to complete this trial. 👋 IMPT non-inferior to IMRT in PFS, OS, superior in tox. @xrtGenomics @imrtlee @seanmmcbride @YaoCMKL
@yaoyu_md @Esanzgarcia @DrMLChua @KaramLab
@Dealmakertech @DanielMaMD @ScottBratman @JJCaudell @safaviaa @HenryParkMD @ajuloorimd @henson_md @RobertFerrisMD @ezrahahn @Dr_AliHosni @ShalinJShahMD
0
0
16
RT @DavidSherMD: @JordanJ65544091 I think the fundamental question is still if, when, and how we should adapt. While I am a "believer," the…
0
3
0
RT @MayoRadOnc: We are 🙌🏽elated to have @tmalouff join our department! Can't wait to have him as an 👨🏽🏫educator and ⚛particle therapy re…
0
4
0